Constellation Pharmaceuticals   Report issue

For profit Phase 2 Phase 3
Founded: Cambridge MA United States (2008)
Status: Acquired by MorphoSys (2021)

Organization Overview

First Clinical Trial
2013
NCT01949883
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Constellation Pharmaceuticals